AI-powered gene discovery enables personalised psoriasis treatments, delivering targeted therapies and better patient outcomes, according to researchers at King’s College London
Recent research from King’s College London has used artificial intelligence‑enabled gene discovery to reveal new insights into psoriasis, paving the way for personalised treatment strategies. By combining machine learning with genetic analysis, scientists have identified key biological pathways that could result in more effective, targeted therapies for individuals living with this chronic skin condition.
Understanding psoriasis
Psoriasis is a common inflammatory skin disease that affects around 1 in 50 people in the UK. Severe psoriasis has a profound impact on quality of life and…